HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Builds OTC Business Through Organic Growth And Bolt-Ons

This article was originally published in The Tan Sheet

Executive Summary

Sanofi-Aventis in its latest quarter made headway toward doubling its OTC business by 2014, reporting 7.4 percent organic growth and 26.3 percent growth including acquisitions in the segment

You may also be interested in...

Sanofi Expands Consumer Health Reach With Minsheng VMS Joint Venture

A joint venture with Minsheng Pharmaceutical Group brings Sanofi-Aventis one step closer to its goal of doubling its consumer health care business in five years and opens a powerful distribution channel in China through which the French firm can market newly acquired supplements

Sanofi Eyes Chattem As Key Building Block For Global OTC Growth

Sanofi-Aventis' $1.9 billion bid for OTC and personal care product firm Chattem offers the French firm a coveted toehold in the sizeable U.S. consumer health care market while also opening potential opportunities in emerging markets

Sanofi-Aventis Will Enter U.S. OTC Market By Paying $1.9 Billion For Chattem

The deal, which is Sanofi's latest attempt to diversity in the face of a looming patent cliff, provides a platform for Rx-to-OTC switches.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts